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Abstract
Background: This study aimed to investigate patterns and context of use of BZP-party pills,
function of use, and positive and negative effects experienced by a sample of New Zealand young
people who had used the products.
Methods: A qualitative study comprised of semi-structured interviews and group discussions.
Results: The sample included 58 young people aged 17–23 years who had used BZP-party pills in
the previous 12 months. Young people were using these substances in a range of settings –
primarily during weekend social occasions – particularly as part of the dance party culture. They
were mostly used for their stimulant properties and to enhance socialisation, and were often taken
in combination with other legal and illicit drugs. Young people had suffered a range of physical and
emotional negative effects, although none of these was reported as being life-threatening or long-
term. Many participants had reduced the frequency with which they used BZP-party pills due to
adverse effects. Potentially risky behaviours identified included taking large doses, mixing BZP-party
pills with alcohol and other substances, and driving whilst under the influence of BZP-party pills.
Conclusion: Findings suggest that young people in this study were not suffering excessive or
dangerous adverse effects. However, potentially risky use of these products raises the issue of the
need for developing harm reduction interventions.
Background
A recent phenomenon to have emerged in New Zealand,
and one which has proven to be popular amongst young
people, is the use of pills containing benzylpiperazine
(BZP), and sometimes also trifluoromethylphenylpipera-
zine (TFMPP). They may also contain additional sub-
stances such as guarana and vitamins.
BZP has been shown to have amphetamine-like effects [1]
and, whilst there is no published literature on the effects
of TFMPP on humans, research in rats indicates that is has
'MDMA-like' properties [2]. At the time of the study
(2006), BZP-containing party pills were legally available
for sale in a wide range of retail outlets in New Zealand
and could also be purchased via the internet and mobile
delivery services. The products, usually known as 'legal
party pills' in New Zealand, are mostly sold in either cap-
sule or pill format, and, at the time of the research, retailed
for between $10 and $60 per pack.
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A 2006 household survey found that one in five people
had ever tried BZP-containing party pills, and one in seven
had used them in the preceding twelve months. Levels of
use were highest among the 18–24 year age range, with
around one third of 18–19 year olds and 38% of 20–24
year olds having used legal party pills in the preceding
year [3]. Their current popularity in New Zealand, partic-
ularly amongst young people, may be related to the rela-
tively restricted and expensive illicit market for drugs such
as ecstasy.
In New Zealand, BZP is currently scheduled as a
'Restricted Substance' under the Misuse of Drugs Amend-
ment Act 2005, meaning that it is illegal to sell or supply
BZP-party pills to anyone under 18 years, and 'free givea-
ways' and print/radio/television advertising of the prod-
ucts are banned. However, at the time of writing
(November 2007) the New Zealand Government was
reviewing the legal status of benzylpiperazine, having
announced that it was recommending that the substance
be reclassified as a Class C1 drug, thus making it illegal.
An announcement regarding any changes in the law is
expected in December 2007. The legal status of BZP is also
currently being reviewed in the UK, whilst several other
countries have already banned it, including Australia and
the US.
There is very limited published data on these substances –
both within New Zealand and internationally – particu-
larly with regard to use of the drugs by young people [4].
The primary aims of this research were to investigate pat-
terns and context of use of BZP-party pills, function of use,
positive and negative effects, and knowledge of safe use
amongst young people aged 16–24 years. Whilst not
reported here, the study also explored aspects of market-
ing and supply, and views of use by young people
amongst 'key experts' employed in associated sectors (e.g.
health, education and the BZP-party pill industry).
The aim of this paper is to describe the patterns and con-
text of BZP-party pill use, and positive and negative effects
experienced by the young users of BZP-party pills who
took part in this study. A brief synopsis of the data pre-
sented here has previously been reported elsewhere [4] –
this paper provides a detailed analysis and interpretation
of those results.
Methods
Qualitative research methods were adopted for this
exploratory study. Data were analysed utilising a general
inductive approach [5], a systematic procedure for analys-
ing qualitative data which draws on grounded theory [6].
In keeping with the study's youth development approach,
the research was also aligned with the six principlesi of the
Youth Development Strategy Aotearoa (YDSA) [7]. Thus,
the researchers worked with young people, where possi-
ble, throughout the set-up, recruitment and data collec-
tion phasesii. This included training and working with
youth 'fieldworkers' who were employed to recruit partic-
ipants, developing relationships with youth organisa-
tions, and consulting young people on the methods used
to attract participants and to collect data. Ethics approval
for the study was granted by the University of Auckland
Human Participants Ethics Committee (ref 2005/279).
Recruitment
The study was publicised via flyers and cards (distributed
in party pill retail outlets, bars and clubs, tertiary educa-
tion campuses, and a range of youth and health organisa-
tions) and advertisements placed in suitable online and
paper-based publications (e.g. student magazine, enter-
tainment websites). 'Snowballing' was also utilised as a
recruitment method, with participants referring their
friends to the research team. This recruitment approach
has shown to be effective in reaching 'hidden' popula-
tions, such as drug users [8].
Inclusion criteria for the study were young people aged
16–24 years old who had used BZP-party pills at least
once in the last 12 months, and who were willing to give
written, informed consent in order to take part. They were
excluded if they, or a close friend or family member, were
involved in the manufacture, distribution or retail of BZP-
party pills. Potential participants were able to indicate
their interest in taking part in the research either via text
or by calling a Freephone number, and were screened over
the telephone to determine their eligibility to participate.
Data collection
Research participants were given the option of taking part
either in an individual interview, a 'friendship interview/
group' (made up of two or more young people known to
each other), or a general focus group (with participants
unknown to one another). Friendship interviews/groups
are widely used in research involving young people and
can provide opportunities to observe natural social net-
works, whilst also aiding recruitment and access to youth
respondents [9]. This proved to be the case with this
study, with the vast majority electing to take part with
friends. Given the younger age of participants, a co-facili-
tator with a youth treatment background was present at
interviews/groups which contained 16–18 year olds.
Interviews and group discussions were semi-structured.
The key questions were shaped by the need to explore
users' experiences (both positive and negative) of a new
substance, about which little was known – and were
developed with input from the project advisory group and
piloted prior to the research commencing. Topics covered
included patterns of use (e.g. accessing products, place ofHarm Reduction Journal 2007, 4:18 http://www.harmreductionjournal.com/content/4/1/18
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use, frequency, dosage etc.), positive and negative effects,
general perceptions of the products, knowledge of safe use
and legislation, and (where appropriate) use of other sub-
stances. Prior to the main discussion, a pre-group/inter-
view questionnaire was given to participants to complete,
which collected additional data on BZP-party pill taking
behaviour and other substance use over the previous six
months. All respondents provided signed, informed con-
sent and received a movie voucher as a 'thank you' for
their contribution to the research.
Interviews and groups were conducted between June and
September 2006, with each lasting between 1 and 1 1/2
hours. They were held in a range of community locations
(e.g. a neighbourhood community centre) and food and
(non-alcoholic) refreshments were provided for partici-
pants.
Analysis
Data from the pre-interview/group questionnaires were
entered into an excel spreadsheet and descriptive statistics
obtained. All interviews and group discussions, except
oneiii, were recorded and transcribed and thematic analy-
sis of the data was undertaken, utilising a general induc-
tive approach [5]. A selection of transcripts was first read
through by the lead researcher and a basic coding frame
developed. Data coding was undertaken with the aid of
computer-assisted qualitative data analysis software (N-
VIVO), with two members of the research team coding
half the transcripts each. The coding frame was developed
and amended with input from both researchers, where
appropriate, during this process. To ensure reliability, the
coded data were then read through by both researchers
and checked for consistency. Analysis of the data was
undertaken with additional input from two further
researchers with different backgrounds, thus adding
another dimension to the analysis process.
Results
The sample
Ten individual interviews, 11 paired interviews and 7
groups (range 3–5 respondents) were conducted, and
comprised a total of 58 young people (28 female and 30
male). The average age of participants, based on pre-
group/interview questionnaire data, was 19.8 years (range
17–23; data missing on 5 cases). The sample was heavily
weighted towards New Zealand European respondents (n
= 49) and included a mix of secondary school students,
university students, full-time or part-time employees, and
an at-home mother. The majority of interviews and
groups were conducted in two large urban centres in New
Zealand.
All but one person had drunk alcohol during the previous
six months (data missing on one person). Twenty two
reported not having smoked cigarettes and 12 reported
having used no illegal drugs during this time. Of those
who reported having used illicit drugs, 34 had used can-
nabis, 30 had used ecstasy, 16 had used LSD (lysergic acid
diethylamide), four had used nitrous oxide, and three or
fewer young people had used 'speed', GHB (gammahy-
droxybutyrate), methamphetamine, 'magic mushrooms',
and ketamine. (Note: respondents could provide more
than one response).
First time use of party pills
Data from the pre-group/interview questionnaire identi-
fied that the mean age of first use of BZP-party pills was
17.4 years (youngest 14 and oldest 22; data missing on
one case). Some had used illicit substances prior to BZP-
party pills, whereas for others (alcohol aside) their first
experience of drug-taking had involved party pills. Most
were introduced to BZP-party pills by a friend or relative
who had used them previously.
First use of the substances appears to be a seminal event
amongst these young people – not least because it was
often a negative experience. In some cases, this was
because it involved taking a large number of pills in com-
bination with alcohol – often on the recommendation of
a friend or peer:
First time I took party pills I was 20. She [friend] took me
to [name of specialist retailer] and gave me a couple of
packets of [name of product]. I had no idea what I'd taken
but I trusted her. Afterwards she told me we'd taken three
times the recommended dosage. [Interview [8]]
This finding again highlights the role of peers and social
networks with regard to initiation into adolescent drug
use, and the fact that friends are a trusted source of advice
and substances [10-12]. However, as evident in the inter-
view extract above, such advice may be ill-informed or
unsafe.
Some young people recalled first time use of BZP-party
pills positively, as being an encounter with something
exciting and new:
A couple of mates gave me some [name of product].They
are really weak, but because it was my first time it was fan-
tastic. I danced my arse off all night. [Interview [19]]
The above two interview extracts also demonstrate the
context of use of the pills – i.e. accompanied by extended
periods of dancing – and the common finding that users
often take many more pills than is 'recommended'. Both
have associated risks, including increased likelihood of
negative effects in the first example, and potential over-
heating and dehydration in the second.Harm Reduction Journal 2007, 4:18 http://www.harmreductionjournal.com/content/4/1/18
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Frequency of use
Data from the pre-group/interview questionnaire showed
that nearly half the sample (n = 25) had used them more
than once a month in the last six months, with 31 partic-
ipants having used them once a month or less during this
time period.
A number of respondents had reduced the frequency with
which they used BZP-party pills. For most, this was due to
the negative side-effects of the products:
I: So you don't take them as much as you used to. Do you
want to tell me a little bit about that?
R1:It's okay at the time but the next day just kills you. And even
at the time it's good but it's never that great like you always
kind of feel a bit....
R2:When you first start it you're like "Wow, this is awesome"
but then...
R1:Yeah, like 3 months, it's not good. It's all, I don't know, it's
relentless. You can't stop it or slow down or anything. Say you're
trying to sleep but nah.
R2:Yeah, I haven't thought about it for a while. You know what
they say. Bad kind of outweighs the good. [Interview [24]]
Others spoke about life changes that had impacted on
their frequency of use (e.g. pregnancy, change of job) or
highlighted that levels of use fluctuated throughout the
year (e.g. increased occasions of use during the summer).
Amount used
The data in this section need to be interpreted with cau-
tion, as the amount of BZP and TFMPP per pill varies con-
siderably between brands (it has been reported that over
120 brands have been available for purchase in New Zea-
land [13]); it is therefore not possible to calculate the
actual amount of these chemicals per individual pill or
capsule.
Young people's behaviour varied with regard to the
number of party pills they were taking on each occasion.
Some were only taking one pill, whereas others were tak-
ing up to six. Many were taking more than the 'recom-
mended amount'iv on the packaging, with a number of
interviewees reporting that they took around two to three
pills per occasion on average. The pre-group/interview
questionnaire identified that on the last occasion of use,
the average number of pills taken was 2.1, with the major-
ity of young people having taken one to two pills (range
one to six).
Where people were taking more than one pill they often
split this amount, and spread it over the course of the BZP-
party pill-taking occasion. Data from the pre-group/inter-
view questionnaire showed that the median time before
the first and subsequent pill(s) taken on the most recent
occasion they had used BZP-party pills, was 75 minutes.
However, some people had taken all the pills at once.
Again, given the variation in amount of BZP and TFMPP
across individual pills and brands, this may mean that
young people experience a greater degree of intoxication
than anticipated. There was also evidence that some
young people titrated their amount against the effects
received:
Oh yeah, you don't even think how many you've taken – I
just, I'll have like three at first and then if that doesn't last
me the night I just take another until I've got the right
energy. [Interview [10]]
Young people generally had a specific pattern of use with
regard to amount used – i.e. some people would always
(or mostly) only take one pill, whereas others would take
three or four on most occasions. This was mostly depend-
ent upon the degree of intoxication they felt comfortable
with. However, the amount used was sometimes varied,
depending on the strength of the products being con-
sumed and the context of use (e.g. smaller doses if being
taken at work):
I use them as a tool. Firstly it was to get wasted but now I'll
take them if I don't want to get too wasted, just take two or
three party pills – 100 mgs at a time – I would be awake
but it wouldn't get me wasted. [Interview [4]]
Some young people also reported that they had reduced
the number of pills they were taking on each occasion in
an attempt to reduce the negative effects of the products.
Drug form and route of administration
The main route of administration for interviewees was
swallowing BZP-party pills in their original form. All par-
ticipants stated that this was their primary means of
ingesting the drug, and few had experimented with other
routes of administration.
A small number had snorted BZP- party pills as a means
of trying something new, and in the expectation that it
would provide a quicker 'hit'. All, however, stated that it
was a 'one-off' occurrence due to suffering negative effects
(e.g. nose bleeds). Other routes of administration
included ingesting BZP powder (commonly known as
"hummer") which was wrapped in a cigarette paper and
swallowed. A minority had also emptied capsules from
BZP-party pill products into drinks and consumed the
substance in liquid form. No young people interviewedHarm Reduction Journal 2007, 4:18 http://www.harmreductionjournal.com/content/4/1/18
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reported injecting BZP or knowing anybody who had.
Whilst IV use has been reported elsewhere [3], it has not
been identified as widespread behaviour, nor specifically
an issue for young people.
Places and context of use
BZP-party pill use was mostly a social activity undertaken
with friends, with the majority of young people using the
substances at night, during the weekend. It was predomi-
nantly associated with clubbing, 'raves' and dance parties
– although some young people were also taking them in
bars or at parties or gatherings in their homes:
Probably just going out to town I suppose, drinking at home,
having a few drinks at home then going to town and then
taking the party pills when you get there. Or maybe having
a party at home or something, drinking alcohol and then
maybe having one party pill or something, just to maybe lift
it a bit. That's typical for me I think. [Interview [7]]
Daytime use of legal party pills was less common. Where
this occurred, it was associated with outdoor use (e.g. at
the beach) or more 'functional' and/or solo activities such
as housework or studying:
I'll take it when I've got heaps of cleaning to do and I'm not
feeling in the mood, if I'm tired. Then it gets done really
well and then I'll just go to bed at the normal time at night.
I take them at 11 am or midday. I get right into things.
[Interview [22]]
A small number of young people claimed to use party pills
in the work place – this was either motivated by a desire
to enhance their working day, or to assist in the recovery
from previous social activities:
Also if I'm really really tired and I know that I have to work,
I'll take a few before I go to work and that will just keep me
awake. And, like, you know, no one knows that you're on
them because you're still – it's not like taking P [metham-
phetamine]  or something where everyone knows that
you're on something. [Interview [21]]
Some young people had driven after taking party pills,
either when travelling to, or returning home, from an all-
night event. In some cases, young people reported that
they took party pills in place of alcohol when they were
the 'designated driver' for the evening. A minority had
also driven whilst 'high' on BZP-party pills. Young people
generally perceived that driving after taking BZP-party
pills was safer than 'drink-driving', both in terms of the
risk of an accident and a driving-related conviction:
Go to town with his mates and get someone to drive, the
sober driver might go on to herbals [party pills] only,
because at least they're in a good mood but they're not
drinking. [Interview [10]]
There is no evidence to support whether BZP-party pills
pose a greater or lesser risk to driving ability, for example
when compared with alcohol. However, a link has been
identified between risk perceptions and impaired driving
behaviour – i.e. people who believe there is a strong like-
lihood of being apprehended, or involved in an accident,
are less likely to drive while intoxicated [14].
Concurrent use of other substances with BZP-party pills
As part of the pre-group/interview questionnaire,
respondents were asked 'what other things do you nor-
mally take with them?' The substance most commonly
cited was alcohol (n = 46 participants). Concurrent use of
cannabis (24), ecstasy (20), LSD (5), methamphetamine
(4), ketamine (3), GHB (3), nitrous oxide (2)v and magic
mushrooms (2) was also reported. Only three people
indicated that they did not use anything else with BZP-
party pills. (Note: participants could provide more than
one response).
The interviews/group discussions revealed that the other
substances used in combination with BZP-party pills
often had a very specific role to play. Cannabis was most
often used during the 'comedown' period to manage the
negative effects experienced during the latter stages of the
drug-taking episode, and to stimulate sleep and appetite:
Awful thing about party pills is that you can't sleep like,
when I have finally been able to go to sleep it's not been a
very nice sleep and doesn't last for long, and so I smoke a
shedload of weed when I'm on party pills because I don't
know, to try to go to bed. [Interview [2]]
Some of the young people in the sample who used ecstasy
took the drugs in combination – either taking BZP-party
pills prior to MDMA as a way of 'kick-starting' the night,
or in reverse to prolong the effects of ecstasy:
Ecstasy wears off more quickly as well, like it's not as long
lasting. If you're going out and you want to go out all night,
you don't want to just go home at three or four – you want
to be up until six, take some party pills to keep going. [Inter-
view [10]]
As highlighted in the findings from the pre-group/inter-
view questionnaire, alcohol was the most popular sub-
stance consumed in combination with BZP-party pills,
despite there being a high level of awareness amongst the
sample that this was not recommended behaviour (note:
this information is often contained on BZP-party pill
packaging). Drinking often took place prior to taking the
substances, as a part of general socialising or in the 'warm-Harm Reduction Journal 2007, 4:18 http://www.harmreductionjournal.com/content/4/1/18
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up' to a big event. After ingesting BZP-party pills, a pro-
portion of the sample reported that they stopped drinking
– either because they found alcohol unpleasant or they
felt sufficiently intoxicated. Others maintained that the
substances increased their capacity to consume large
amounts of alcohol without experiencing usual feelings of
intoxication, and took BZP-party pills as a 'sobering'
device:
I might have been thinking of taking only two that night but
I was feeling quite drunk so I took a third one. And then 45
minutes later I felt a bit sober and stuff and that's fine. And
I'm always dancing when I take them as well, which is a
really good combination to sober up as well. [Interview
[15]]
Indeed, a number stated that they specifically took party
pills when 'drunk' to enable them to carry on socialising.
Use of the substances after consuming large amounts of
alcohol has a number of risks given the potential for the
products to mask actual levels of intoxication and, as evi-
dent in the participant's comments above, may result in
an increased number of pills consumed.
Positive effects of use
A number of themes were identified when respondents
were asked to describe what they viewed as the positive
effects of BZP-party pill use. A key positive association
with the products was their stimulant properties, with
young people highlighting that use of the substances ena-
bled them to stay awake for longer to undertake a wide
range of activities. These included dancing, general social-
ising, work, outdoor pursuits and study:
Oh it was amazing. I was just studying and remembering
everything that I studied, just sort of going and going like a
machine. I've never studied that well so I was impressed
with myself at the time. [Interview [3]]
By the time I get to the weekend I am pretty tired and I've
got to make the most of the time that I have with my friends
a lot of the time. I make the most of going out and dancing
so I don't get tired because I enjoy that part of my life so
much. Energy [party] pills give me the opportunity to make
the most of it for as long as I can. [Interview [19]]
Many users reported that BZP-party pills made them feel
confident and relaxed in social situations, and thus the
products facilitated social interactions. As a result, existing
friendships were strengthened and new alliances were
sometimes formed:
With party pills, um, I want to talk a lot, you've probably
heard that before. And we don't want to dance, we just sit
down and talk for hours and really enjoy, really get into it
and share our deepest and darkest secrets and it's great.
[Interview [12]]
Several young people spoke about the nature of the 'high'
when considering positive effects of BZP-party pill use.
They described the "buzz" experienced during the 'peak' of
the drug-taking occasion, alongside a range of sensory and
mind altering effects. A number of young women also
identified weight loss as a positive outcome of use. Some
were using party pills specifically as a weight loss device,
whilst others reported this as an added 'bonus' when
socialising:
Me and [name of friend]have got the same figure and
stuff. We have little podgy bits around here so we get the
permanent creases. But after party pills you're all sunken in
and you don't have those. It makes you so much more con-
fident. [Interview [25]]
Such accounts of positive effects are in keeping with the
experiences of users of other substances, particularly
ecstasy [15,16].
Adverse/negative effects
A wide range of adverse or negative effects of BZP-party
pills were self-identified by respondents, although it
should be noted that it is reasonably difficult to attribute
many of these to BZP-party pills alone. A combination of
BZP-party pill consumption, concurrent use of alcohol
and other substances, extended periods of exertion, lack
of sleep, and dehydration may all contribute to these neg-
ative effects.
The adverse effects identified by the study participants can
be divided into two categories: immediate effects (i.e. those
that were experienced whilst intoxicated) and after-effects
(experienced once the effects of the drugs had worn off,
commonly referred to as the 'comedown' period).
Immediate effects (effects while intoxicated)
The negative immediate effects of the substances, as
described by respondents, were predominantly physical.
Those most commonly cited included: headaches, vomit-
ing and nausea, dehydration/inability to quench thirst,
racing heart, sore or shaking body, loss of appetite, trem-
bling mouth or jaw, and an inability to urinate. Others
mentioned less often included impaired sexual perform-
ance, dizziness, sore eyes, stomach pains, teeth grinding,
increased rates of smoking, and bleeding nose (from
snorting). Most young people interviewed reported that
they had experienced a number (but not all) of these
immediate adverse effects:Harm Reduction Journal 2007, 4:18 http://www.harmreductionjournal.com/content/4/1/18
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Cos my jaw goes absolutely mental. It screws up. It clicks
every time I move it. Everybody always comments on my
mouth. [Interview [5]]
The fact that you can't urinate. I don't know about anybody
else, but I can't go to the bathroom. [Interview [6]]
A smaller number of young people had also suffered neg-
ative emotional or psychological effects whilst intoxi-
cated. In contrast to the physical effects noted above, these
were generally reported as being rare occurrences that did
not happen on a regular basis. They included experiencing
feelings of tension, agitation, anxiety, or paranoia. When
this occurred, most young people reported that they with-
drew from social interactions:
I find party pills, you get times particularly for me towards
the end of the night in particular, like the more like twisted
euphoric party pills with the TMVP [TFMPP] stuff. They're
like, get moments of real sort of withdrawn headspace
where you just sort of like feel a bit funny and you don't
want to socialise and your sort of thoughts get a bit weird.
[Interview [11]]
After-effects ('come-down')
Adverse effects experienced during the latter stages of the
effects of BZP-party pills use were widely reported. These
occurred in the hours and, in some cases, days after taking
the products. In particular, an inability to sleep and a lack
of appetite were two key issues identified. Other adverse
physical effects included: tiredness and sluggishness,
headaches, sore or dry mouth or jaw, and an aching/shak-
ing body:
At the end of the night you don't really feel tired. Like your
body feels tired. When you think about it all you want to do
is lie down. Your body is exhausted but your mind keeps
going. And yeah, you just feel terrible and shaky and weak.
You close your eyes but you keep seeing things and your
mind won't stop. [Interview [24]]
In addition, during this period, many young people stated
that they suffered a range of negative emotional or psy-
chological effects, including feelings of depression, ten-
sion and anxiety. For some participants, these were
present the day after using BZP-party pills, whereas for
others they extended well into the following week.
As a result of the impact of the substances on physical and
emotional health, many young people reported that they
withdrew from social interactions, or that their work or
study performance had been impaired in the day(s) fol-
lowing BZP-party pill use:
Definitely the next night if I have to go to work, I can't
work, I'm extremely slow. Everyone gets really pissed off.
So, I try not to go to work the next day. [Interview [7]]
Sort of depression, but not really, it's like, you know, when
a woman gets her period she just really starts nagging at
people and stuff like that, it's more like that. It's hard to
explain really. You don't feel really sad or anything. You
just feel tired and want to go to sleep and other people come
in and try and try to keep you awake and you're like 'fuck
off man'. [Interview [18]]
Most young people considered the 'comedown' period
induced by BZP-party pills to be very unpleasant, and
those who had experienced the use of other stimulants
considered it to be worse than with illegal drugs such as
ecstasy. Similarly, for the vast majority, alcohol hangovers
were perceived to be more manageable than those
induced by BZP-party pill use.
Discussion
This research comprises an in-depth exploration of young
people's use of substances containing BZP. Although
mainly a New Zealand phenomenon, the issue is emer-
gent in other countries. Young people appear to be the
majority of users of these products [3] and thus these
results provide a unique and novel insight into their use.
A number of limitations exist which should be borne in
mind when interpreting our data. Qualitative studies are
not designed to produce generalisable results and this,
combined with the small sample size, means that the find-
ings may not be representative of the overall population –
or young people specifically. The research may have
attracted only those with more 'extreme' experiences or
views of the topic. In particular, some young people were
aware of media reports of efforts to see the products
banned and were pleased to be given the opportunity to
contribute to this debate. Other potential limitations
include the possible clustering of experiences due to con-
ducting friendship groups/interviews and the possibility
of young people exaggerating their stories. Furthermore, a
common characteristic of the BZP-party pill users inter-
viewed was that they appeared to be a high functioning
group, in that most were studying or employed, and they
were articulate, punctual and reliable with respect to their
participation in the study. This could be a product of the
recruitment strategy, or may support previous claims that
drug users from the dance party culture – with which BZP-
party pills are strongly associated in New Zealand – are
not as economically and socially marginalised as other
regular drug misusers [17,18].
The study has revealed BZP-party pills fulfilling a range of
functions for young people, with the products being usedHarm Reduction Journal 2007, 4:18 http://www.harmreductionjournal.com/content/4/1/18
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in a variety of situations and social settings – and has con-
firmed anecdotes that primarily linked the use of these
substances with the dance party culture for the purpose of
additional energy and enhancement of socialisation.
Other uses have also been identified in this research,
including BZP-party pills' role as a study aid, and fulfilling
a weight loss function. Patterns of BZP-party pill use
appear to be similar to usual patterns of substance use
amongst young people in this age range. For example,
experimentation is commonplace, much learning occurs
through 'trial and error', levels of use fluctuate throughout
the year, and mixing a range of substances (both legal and
illegal) is common [19-21]. The perceived benefits of
BZP-party pill use, such as increased energy and confi-
dence, and enhanced sociability have been reported in
other studies of illegal drug use [22,23].
The apparent trend with regard to young people reducing
their frequency of use of BZP-party pills, as well as
amount across a single drug-taking occasion, implies that
use of BZP-party pills may be a phase of experimentation.
Whilst this hypothesis has also been discussed in the
media by individuals working in the health sector [24] it
clearly requires further exploration. Regardless of whether
young people go on to use BZP-party pills on a more reg-
ular basis, novice users should be a key target for harm
reduction interventions, given the potentially risky behav-
iours they appear to engage in when trying the products
for the first time (e.g. taking large amounts) and their reli-
ance on (sometimes unsafe) advice from friends.
Given its stimulant effects, the way in which the products
are marketed, and the cost of MDMA in New Zealand rel-
ative to BZP-party pills, it is perhaps not surprising that
the substances are being used in similar ways to those seen
amongst users of ecstasy in other countries; for example,
prolonged periods of dancing in crowded and heated con-
ditions, use to assist with weight loss, and the use of other
substances to manage the 'comedown' period [12,22,25].
In addition, there was some commonality between the
substances in terms of the negative effects identified,
including mood fluctuations, broken sleep, lethargy and
depression in the period after taking the drug [25-28].
This would suggest that, in the absence of research evi-
dence about BZP-party pills, harm reduction messages
from the party drug culture may be extrapolated to meet
the needs of BZP-party pill users. This may include the
importance of keeping close with trusted friends, taking
'time out' during long periods of dancing, and monitoring
fluid levels and food intake, both when taking the sub-
stances and in the period after the effects of the drugs have
worn off.
The research has identified a range of negative effects
reported by BZP-party pill users. Some of the negative
effects identified, such as tachycardia, can almost certainly
be attributed to the pharmacological effects of BZP. How-
ever, many others (e.g. tiredness and lethargy) may be
partly due to BZP's effect on sleep, combined with the
effect of strenuous dancing for extended periods. In addi-
tion, the immediate and delayed combined physical and
psychological effects of large quantities of alcohol or other
substances combined with BZP-party pills are unknown.
Clearly, further investigation is necessary to identify
which effects specifically relate to the chemicals in BZP-
party pills, and which are a by-product of associated
behaviour and activities. However, in either case, issues
such as sleep deprivation are important when considering
young people given the links between sleep loss and
reduced academic performance, car accidents, and gas-
trointestinal problems [29,30]. In addition, given the
short duration in which BZP-party pills have been in exist-
ence, unlike other party drugs such as ecstasy, any longer-
term effects of the substances are yet to be observed.
This study found limited evidence of significant short
term harms having been experienced. Again, this may be
an artefact of the make-up of our sample, being a rela-
tively 'high- functioning' group. Despite this, the study
has provided evidence that some young people appear to
be participating in a range of risky behaviours with regard
to BZP- party pills, including mixing substances, driving
whilst under the influence of BZP-party pills, and taking
larger numbers of BZP-party pills than recommended.
These risky behaviours are not specific to BZP-party pills,
and mimic behaviours seen amongst those who consume
alcohol and other drugs [12,31]. Although there is cur-
rently no evidence specifically on the impact of BZP-party
pills on driving, associated issues such as driver fatigue for
those driving home after a full night of dancing and no
sleep could be highlighted to users. Other research has
identified that a lack of alternative transport options and
cost have contributed to the reasons for people driving
after using drugs [31]. This is likely to be the case for our
youth sample, given their younger age and New Zealand's
traditionally limited public transport systems.
The results raise a number of issues for harm reduction, in
respect to the effects of use, context of use and potential
risky behaviours as outlined above. The current, uncertain
future of these products does not negate the need to pro-
vide accurate and appropriate harm reduction messages to
young people and to explore environmental harm reduc-
tion issues. Even if ultimately banned, it is likely that sim-
ilar products will emerge on the licit market. Moreover,
BZP might become available illegally, or it may also
emerge mixed in with other substances – evidence for
which currently exists [32].Harm Reduction Journal 2007, 4:18 http://www.harmreductionjournal.com/content/4/1/18
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Conclusion
This study is the first to explore issues around young peo-
ple's use of BZP-party pills. Our findings suggest that
young people in this study were not suffering excessive or
dangerous adverse effects, despite reports of such events in
other studies. However, potentially risky use of these
products raises the issue of the need for developing harm
reduction interventions. Information provision on issues
such as not mixing with alcohol and other drugs, limiting
amount taken, potential negative effects of the drugs and
risky drug-taking contextual information may play a part
in reducing the harm associated with use of BZP-party
pills.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
RB participated in the study design, conducted and man-
aged data collection and analysis, drafted the manuscript
and edited the manuscript.
JS conceived the study, participated in its design and anal-
ysis, drafted the manuscript and edited the manuscript
Both authors read and approved the final manuscript.
Appendix
i Youth development 1) is shaped by the 'big picture'; 2) is
about young people being connected; 3) is based on a
consistent strengths-based approach; 4) happens through
quality relationships; 5) is triggered when young people
fully participate; 6) needs good information.
ii  A youth development approach would also ideally
include 'member checking' by young people during the
analysis stage of research in order to provide feedback on
findings. Due to time constraints, this was not undertaken
and is recognised as a limitation of the study.
iii  Due to confidentiality concerns, one participant
requested that the interview was not audio-taped. In order
that the data was still recorded, the researcher took hand-
written notes during the interview.
iv No recommended dose actually exists, as these are not
medicinal products.
v Use of nitrous oxide was also mentioned by several peo-
ple during the interview/group discussions, although not
noted in the pre-group/interview questionnaire.
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